Journal of Functional Foods (May 2022)
An ACE inhibitory peptide from Isochrysis zhanjiangensis exhibits antihypertensive effect via anti-inflammation and anti-apoptosis in HUVEC and hypertensive rats
Abstract
Microalgae are primary producers in marine ecosystems, and have been diffusely used in medicine and food. In this research, we evaluated the protective effects of polypeptides from microalgae, Isochrysis zhanjiangensis (EMFGTSSET, ETT) on endothelial injury in angiotensin II (Ang II)-induced human umbilical vein endothelial cells (HUVEC). The results showed that ETT inhibited the fluorescence intensity of intracellular reactive oxygen species (ROS), and reduces the expression of related cytokines, such as IL-1β, IL-8, TNF-α, iNOS, COX-2, ET-1, AT-1, and adhesion factor. It blocks inflammation and apoptosis through mitogen-activated protein kinases (MAPK), nuclear factor κB (NF-κB) and serine/threonine kinase (Akt) signal pathways, thereby alleviating endothelial damage. Meanwhile, ETT (IC50 = 15.08 μM) antagonizes Angiotensin-I Converting Enzyme (ACE) in a non-competitive binding mode, and has an antihypertensive effect in spontaneously hypertensive rats (SHR). Therefore, ETT has excellent effect in regulating hypertension, can become the main component of potential functional food for the prevention of cardiovascular diseases, and further improve the use value of Isochrysis Zhanjiangensis.